Literature DB >> 2540244

Zoster in normal children after varicella vaccine.

S A Plotkin, S E Starr, K Connor, D Morton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2540244     DOI： 10.1093/infdis/159.5.1000

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  10 in total

Review 1.  Varicella vaccination--a critical review of the evidence.

Authors:  S A Skull; E E Wang
Journal:  Arch Dis Child       Date:  2001-08       Impact factor: 3.791

2.  A varicella-zoster virus mutant impaired for latency in rodents, but not impaired for replication in cell culture.

Authors:  Aruna P N Ambagala; Tammy Krogmann; Jing Qin; Lesley Pesnicak; Jeffrey I Cohen
Journal:  Virology       Date:  2010-02-08       Impact factor: 3.616

Review 3.  Varicella-zoster virus.

Authors:  A M Arvin
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

Review 4.  Impact of varicella vaccine on varicella-zoster virus dynamics.

Authors:  D Scott Schmid; Aisha O Jumaan
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

5.  Measuring the burden of herpes zoster and post herpetic neuralgia within primary care in rural Crete, Greece.

Authors:  Christos D Lionis; Constantine I Vardavas; Emmanouil K Symvoulakis; Maria G Papadakaki; Foteini S Anastasiou; Maria D Antonopoulou; Charalampos M Apostolakis; Stelios A Dimitrakopoulos; George I Fountakis; Ilias A Grammatikopoulos; John D Komninos; Dimitris K Kounalakis; Eva S Ladoukaki; Kornilia V Makri; Chrysa S Petraki; Nikos G Ploumis; Dimitra P Prokopiadou; Ioanna N Stefanaki; Nikos A Tsakountakis; Ioanna G Tsiligianni; Emmanouil N Tzortzis; Aggeliki A Vasilaki; Theodoros K Vasilopoulos; George E Vrentzos
Journal:  BMC Fam Pract       Date:  2011-12-06       Impact factor: 2.497

6.  The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003.

Authors:  W Katherine Yih; Daniel R Brooks; Susan M Lett; Aisha O Jumaan; Zi Zhang; Karen M Clements; Jane F Seward
Journal:  BMC Public Health       Date:  2005-06-16       Impact factor: 3.295

7.  Safety and immunogenicity of single dose live attenuated varicella vaccine (VR 795 Oka strain) in healthy Indian children: a randomized controlled study.

Authors:  Monjori Mitra; Mma Faridi; Apurba Ghosh; Nitin Shah; Raju Shah; Suparna Chaterjee; Manish Narang; Nisha Bhattacharya; Gandhali Bhat; Harish Choudhury; Ganesh Kadhe; Amey Mane; Sucheta Roy
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 8.  Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data.

Authors:  G S Goldman; P G King
Journal:  Vaccine       Date:  2012-06-01       Impact factor: 3.641

Review 9.  Mechanisms that determine plasma cell lifespan and the duration of humoral immunity.

Authors:  Ian J Amanna; Mark K Slifka
Journal:  Immunol Rev       Date:  2010-07       Impact factor: 12.988

10.  Herpesviral Fcgamma receptors: culprits attenuating antiviral IgG?

Authors:  Matthias Budt; Henrike Reinhard; Arndt Bigl; Hartmut Hengel
Journal:  Int Immunopharmacol       Date:  2004-09       Impact factor: 4.932
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.